GABA induces activity dependent delayed-onset uncoupling of GABA/benzodiazepine site interactions in neocortical neurons

J Biol Chem. 2005 Jun 3;280(22):20954-60. doi: 10.1074/jbc.M500131200. Epub 2005 Apr 1.

Abstract

Changes in the function of type A gamma-aminobutyric acid receptors (GABA(A)Rs) are associated with neuronal development and tolerance to the sedative-hypnotic effects of GABA(A)R positive modulators. Persistent activation of GABA(A)Rs by millimolar concentrations of GABA occurs under physiological conditions as GABAergic fast-spiking neurons in neocortex and cerebellum exhibit basal firing rates of 5 to 50 Hz and intermittent rates up to 250 Hz, leaving a substantial fraction of synaptic receptors occupied persistently by GABA. Persistent exposure of neurons to GABA has been shown to cause a down-regulation of receptor number and an uncoupling of GABA/benzodiazepine (BZD) site interactions with a half-life of approximately 24 h. Here, we report that a single brief exposure of neocortical neurons in primary culture to GABA for 5-10 min (t(1/2) = 3.2 +/- 0.2 min) initiates a process that results in uncoupling hours later (t(1/2) = 12.1 +/- 2.2 h). Initiation of delayed-onset uncoupling is blocked by co-incubation with picrotoxin or alpha-amanitin but is insensitive to nifedipine, indicating that uncoupling is contingent upon receptor activation and transcription but is not dependent on voltage-gated Ca2+ influx. Delayed-onset uncoupling occurs without a change in receptor number or a change in the proportion of alpha1 subunit pharmacology, as zolpidem binding affinity is unaltered. Such activity dependent latent modulation of GABA(A)R function that manifests as delayed-onset uncoupling may be relevant to physiological, pathophysiological, and pharmacological conditions where synaptic receptors are transiently exposed to GABA agonists for several minutes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amanitins / pharmacology
  • Animals
  • Benzodiazepines / chemistry
  • Binding Sites
  • Calcium / metabolism
  • Cerebellum / metabolism
  • Cerebral Cortex / metabolism
  • DNA, Complementary / metabolism
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Inhibitory Concentration 50
  • Kinetics
  • Models, Biological
  • Neurons / metabolism*
  • Nifedipine / pharmacology
  • Osmosis
  • Picrotoxin / pharmacology
  • Protein Binding
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA / metabolism*
  • Receptors, GABA-A / chemistry
  • Receptors, GABA-A / physiology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Transcription, Genetic
  • Zolpidem
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Amanitins
  • DNA, Complementary
  • Pyridines
  • Receptors, GABA
  • Receptors, GABA-A
  • Picrotoxin
  • Benzodiazepines
  • gamma-Aminobutyric Acid
  • Zolpidem
  • Nifedipine
  • Calcium